EFFICACY AND SAFETY OF VWF CONCENTRATES IN A COHORT OF 93 PATIENTS WITH TYPE 3 VON WILLEBRAND DISEASE ENROLLED IN 3WINTERS-IPS: RESULTS OF THE 2-YEAR PROSPECTIVE CLINICAL OBSERVATION

被引：0
|
作者：
Peake, I. R. [1 ]
Federici, A. B. [2 ]
机构：
[1] Univ Sheffield, Dept Dent & Hlth, Fac Med, Sheffield, S Yorkshire, England
[2] Univ Milan, L Sacco Univ Hosp, Hematol & Transfus Med, Milan, Italy
来源：
HAEMOPHILIA | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-44
引用
收藏
页码：46 / 47
页数：2
相关论文
共 50 条
  • [31] Impact of platelet reactivity on individual thrombin generation in type 3 and 2 von willebrand disease: results from a small prospective study
    Szanto, T.
    Jokela, V. H.
    Jouppila, A.
    Lassila, R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 : 150 - 150
  • [32] CLINICAL-MOLECULAR PREDICTORS OF THROMBOCYTOPENIA AND RISK OF BLEEDING IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 2B: A PROSPECTIVE STUDY IN A COHORT OF 67 PATIENTS
    Federici, A. B.
    Baronciani, L.
    Castaman, G.
    Mannucci, P. M.
    Canciani, M. T.
    Bucciarelli, P.
    Pecci, A.
    Lenting, P. L.
    De Groot, P. G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 378 - 378
  • [33] BIMEKIZUMAB EFFICACY AND SAFETY IN PATIENTS WITH PSORIATIC ARTHRITIS AND PSORIASIS: UP TO 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES
    Thaci, Diamant
    Gottlieb, Alice B.
    Asahina, Akihiko
    Lebwohl, Mark
    McInnes, Iain B.
    Warren, Richard
    Boehncke, Wolf-Henning
    Ink, Barbara
    Bajracharya, Rajan
    Coarse, Jason
    Merola, Joseph F.
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [34] Specific therapeutic approach in type 3 von Willebrand disease: Efficacy of a concentrate (vWF SD-35-DH) devoid of FVIII in patients undergoing surgical procedures.
    Borel-Derlon, A
    Federici, AB
    Scharrer, I
    Stieltjes, N
    Goudemand, J
    Rothschild, C
    Claeyssens, S
    Lee, CA
    Borg, JY
    Fressinaud, E
    Polack, B
    Mazurier, C
    Berntorp, E
    Tellier, Z
    Bridey, F
    Mannucci, PM
    BLOOD, 2001, 98 (11) : 708A - 708A
  • [35] CLINICAL-MOLECULAR PREDICTORS OF THROMBOCYTOPENIA AND RISK OF BLEEDING IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 2B: A PROSPECTIVE STUDY IN A COHORT OF 67 PATIENTS.
    La Marca, S.
    Rubini, V
    Punzo, M.
    Cozzi, G.
    Canciani, M. T.
    Baronciani, L.
    Mannucci, P. M.
    Castaman, G.
    Pecci, A.
    Lenting, P. J.
    De Groot, P. G.
    Federici, A. B.
    HAEMATOLOGICA, 2008, 93 : S28 - S29
  • [36] Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study
    McInnes, Iain B.
    Kato, Koji
    Magrey, Marina
    Merola, Joseph F.
    Kishimoto, Mitsumasa
    Haaland, Derek
    Chen, Liang
    Duan, Yuanyuan
    Liu, Jianzhong
    Lippe, Ralph
    Wung, Peter
    RHEUMATOLOGY AND THERAPY, 2023, 10 (01) : 275 - 292
  • [37] Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study
    Iain B. McInnes
    Koji Kato
    Marina Magrey
    Joseph F. Merola
    Mitsumasa Kishimoto
    Derek Haaland
    Liang Chen
    Yuanyuan Duan
    Jianzhong Liu
    Ralph Lippe
    Peter Wung
    Rheumatology and Therapy, 2023, 10 : 275 - 292
  • [38] The efficacy and safety of linagliptin in Patients with Type 2 diabetes with or without renal disease: Results of a comprehensive Phase 3
    Cooper, M.
    von Eynatten, M.
    Emser, A.
    Patel, S.
    Woerle, H. J.
    Katsadze, V.
    DIABETES & METABOLISM, 2012, 38 : A103 - A103
  • [39] Long-term safety and efficacy of intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis type II: 2-year results from a phase 2/3 extension study
    Muenzer, Joseph
    Burton, Barbara K.
    Harmatz, Paul
    Gonzalez Gutierrez-Solana, Luis
    Ruiz-Garcia, Matilde
    Jones, Simon A.
    Guffon, Nathalie
    Inbar-Feigenberg, Michal
    Bratkovic, Drago
    Li, Xiaoxi
    Yee, Karen S.
    Alexanderian, David
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S73 - S74
  • [40] The Impact of Continuous Subcutaneous Insulin Infusion Therapy on Efficacy and Safety in a Cohort of Type 1 Diabetes Patients: A 3-Year Prospective Study
    Melidonis, Andreas
    Kamaratos, Alexandros
    Angelidi, Angeliki
    Thomakos, Petros
    Vrakas, Spiridon
    Bakalis, John
    Fousteris, Evangelos
    Iraklianou, Stella
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 (03) : 159 - 163
12345